Skip to content
Screener

Unicycive Therapeutics, Inc. UNCY Q2 2026 earnings

Reported August 12, 2026 · Before market open

EPS-$0.06Beat by $0.41
Revenue estimate$22.2M
EPS estimate-$0.47

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$902.8K
EPS estimate-$0.32

FAQ

When did Unicycive Therapeutics, Inc. report Q2 2026 earnings?
Unicycive Therapeutics, Inc. (UNCY) reported Q2 2026 earnings on August 12, 2026 before market open.
What were Unicycive Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Unicycive Therapeutics, Inc. reported eps of $-0.06 for Q2 2026.
Did Unicycive Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.47 by $0.41.
How did Unicycive Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 88.5% from $-0.52.
Where can I find Unicycive Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001213900-26-088061) and the 10-Q periodic report (0001213900-26-088013) directly on SEC EDGAR. The filing index links above go to sec.gov.